Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PJ4S | ISIN: DK0061123312 | Ticker-Symbol: 96X
Frankfurt
28.03.24
09:59 Uhr
3,910 Euro
-0,050
-1,26 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
FLUOGUIDE A/S Chart 1 Jahr
5-Tage-Chart
FLUOGUIDE A/S 5-Tage-Chart

Aktuelle News zur FLUOGUIDE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.03.Minutes from Annual General Meeting in FluoGuide A/S215COPENHAGEN, DENMARK / ACCESSWIRE / March 20, 2024 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company") held its annual general meeting on 20 March 2024.To the shareholders of FluoGuide A/SThe Annual...
► Artikel lesen
13.03.FluoGuide A/S: Chief Financial Officer Ole Larsen Buys Shares187KØBENHAVN, DK / ACCESSWIRE / March 13, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - 13 March 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today announces that Ole Larsen (CFO) has bought...
► Artikel lesen
08.01.FluoGuide A/S: FluoGuide Provides Strategic Update and Outlines Development Plans Towards Commercialization of FG001208KØBENHAVN, DENMARK / ACCESSWIRE / January 8, 2024 / FluoGuide A/S (STO:FLUO)Strong phase II data on FG001 in three indications: brain, head & neck, lung cancersAssessing potential of photothermal therapy...
► Artikel lesen
08.12.23FluoGuide A/S: FluoGuide Raises SEK 12 million through Exercise of Warrants368KØBENHAVN, DK / ACCESSWIRE / December 08, 2023 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a pioneer in the cutting-edge field of precision cancer...
► Artikel lesen
29.11.23FluoGuide A/S Publishes Interim Report for the Period January - September 2023371KØBENHAVN, DENMARK / ACCESSWIRE / November 29, 2023 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 29 November 2023 - FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the...
► Artikel lesen
21.11.23FluoGuide A/S: FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology conference284Oral presentation outlines positive efficacy and safety dataConfirms interim data showing FG001 met primary endpoint, with cancer lit up in 16 /16 (100%) patients, and was very well toleratedSeveral...
► Artikel lesen
04.10.23FluoGuide imaging agent wins FDA orphan drug designation for glioma surgery2
03.10.23FluoGuide A/S: FluoGuide receives FDA Orphan Drug Designation for FG001 in High-Grade Glioma270KØBENHAVN, DENMARK / ACCESSWIRE / October 3, 2023 / FluoGuide A/S (STO:FLUO)Orphan status applies to visualization of malignant tissue during surgeryOrphan Drug Designation facilitates the development...
► Artikel lesen
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1